Volume 29, Issue 3 pp. 111-115
Review

A review of the trends of lymphomas in the equatorial belt of Africa

Emily A. Rogena

Emily A. Rogena

Department of Human Pathology and Oncology, University of Siena, Siena, Italy

Department of Pathology, University of Nairobi, Nairobi, Kenya

Search for more papers by this author
Giulia De Falco

Giulia De Falco

Department of Human Pathology and Oncology, University of Siena, Siena, Italy

Search for more papers by this author
Karin Schurfeld

Karin Schurfeld

Department of Human Pathology and Oncology, University of Siena, Siena, Italy

Pathologic Anatomy Asl8, Montevarchi, Siena, Italy

Search for more papers by this author
Lorenzo Leoncini

Corresponding Author

Lorenzo Leoncini

Department of Human Pathology and Oncology, University of Siena, Siena, Italy

Department of Human Pathology and Oncology, University of Siena, Via delle Scotte, 6–53100 Siena, Italy.Search for more papers by this author
First published: 30 November 2010
Citations: 6

EAR and GDF wrote the paper, KS conducted epidemiological studies, LL coordinated the study. The Authors declare that there are no conflicts of interest. Study was funded by Fondazione Monte Paschi Siena, Italy.

No duplicate publication or submission elsewhere of any part of the work has been performed.

Abstract

Lymphomas represent one of the most frequent cancer types in Africa. In particular, approximately 30 000 non-Hodgkin lymphomas occur in the equatorial belt of Africa each year and these tumours are in among the top-ten cancers in this geographical region. Several pathogens and environmental factors have been detected in association with these tumours, suggesting that they may contribute to lymphomagenesis. Unfortunately, there are still striking differences between developed and African countries in terms of early detection, diagnosis and treatment of lymphomas. Of note, the disease burden appears to be increasing in Africa. In addition, a much lower cure rate in the low-income countries suggests that the difference in mortality will even become more pronounced in future. Therefore, improving diagnosis is crucial as without it, neither meaningful research projects nor effective patient management can be instituted. In this review, we will summarize the state-of-the-art of lymphoma epidemiology, pathobiology and therapy, and will highlight the still existing gaps between developed and African countries. Copyright © 2010 John Wiley & Sons, Ltd.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.